California State Teachers Retirement System (CalSTRS)’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Other funds holding GALT
WANY
GWM
California State Teachers Retirement System (CalSTRS)'s GALT Position: Q2 2025 in Review
California State Teachers Retirement System (CalSTRS) sold out of Galectin Therapeutics (GALT) in Q2 2025, closing a stake of 1,476 shares — an estimated $1.8K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in GALT in Q2 2014 and held it in 16 quarters. The position peaked at $454K in Q2 2014. 86 funds tracked by Wall St. Rank hold GALT as of Q2 2025.
- California State Teachers Retirement System (CalSTRS) reported no remaining Galectin Therapeutics position as of Q2 2025 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 1,476 Galectin Therapeutics shares in Q2 2025, an estimated $1.8K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Galectin Therapeutics in Q2 2014 and held it in 16 quarters.
- California State Teachers Retirement System (CalSTRS)'s Galectin Therapeutics position peaked at $454K in Q2 2014.
- 86 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2025.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.